NSE
HALEOSLABS
ISIN
INE320X01016

HALEOS LABS

Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals

₹1,402.30

+₹3.50 (+0.25%)

NSE close ·

HALEOS LABS closed at ₹1,402.30 on 9 Nov 2026, up 0.25% on the day, and is up 19.75% over the past year.

52-week range21.0% below high
₹1,091.10₹1,774.00
TodayVolume 250
₹1,390.00₹1,425.00

Price history

Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹1,126.50 to ₹1,690.10.

Price returns, excl. dividends. 3Y, 5Y and Max are annualised.

Fundamentals

Market cap
₹424 Cr
Industry P/E
35.5
Dividend yield
0.11%

Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.

Quarterly results

HALEOS LABS quarterly results
QuarterRevenueNet profitYoY profitEPS
Jun 2026₹73.41 Cr₹1.84 Cr—₹8.75

Armor risk check

HALEOS LABS moves about 3× as much as the market

Volatility, past year

HALEOS LABS41%
Nifty 50015%

Worst fall, past year

HALEOS LABS−22%
Nifty 500−15%

Compared with the Nifty 500 over the past 12 months.

Check it against your portfolio in the app

FAQs

What is HALEOS LABS's share price today?

HALEOS LABS (NSE: HALEOSLABS) closed at ₹1,402.30 on 9 Nov 2026, up 0.25% from the previous close of ₹1,398.80. It traded between ₹1,390.00 and ₹1,425.00 that day.

What are HALEOS LABS's 52-week high and low?

Over the last 52 weeks HALEOS LABS traded between ₹1,091.10 and ₹1,774.00, adjusted for splits and bonuses.

What are HALEOS LABS's NSE symbol, BSE code and ISIN?

HALEOS LABS has NSE symbol HALEOSLABS, ISIN INE320X01016.

How has HALEOS LABS performed over 1, 3 and 5 years?

HALEOS LABS's share price return: 1Y +19.75%, 3Y +39.72% a year, 5Y +9.67% a year. Dividends are not included.

Does HALEOS LABS pay a dividend?

Yes. HALEOS LABS's latest dividend went ex on 23 Sep 2026: Final · ₹1.50 per share. Dividends over the past year come to a yield of 0.11% at the latest close.

What is HALEOS LABS's market cap?

HALEOS LABS's market cap is ₹424 Cr at the close on 9 Nov 2026.

Which sector is HALEOS LABS in?

HALEOS LABS is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).

For information only. Not investment advice or a research report. Past performance does not guarantee future returns.

Full disclaimer

See how HALEOS LABS fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app